PBM Capital — 2022 Investments
1 investments dated 2022 · listed companies and verified rows first · show all
Taysha Gene Therapiestayshagtx.comin𝕏NASDAQ: TSHANov 2022SEC filingmedium confidence
Taysha Gene Therapies develops and commercializes gene therapies for monogenic diseases of the central nervous system, serving patients with rare and larger CNS conditions.
BiotechDeep TechDigital HealthHealthtechMedical DevicesTexas, US
R.A. Session II(Executive Officer, Director)Sean P. Nolan(Chief Executive Officer and Board Chairman)in
BoardSean Nolan(Director)
Board seatPaul B. Manning· per SEC Form D · $30M raise · filed Nov 2022
Co-investorsGV (Google Ventures)
Rows marked “SEC filing” are inferred from directors named on the company's SEC Form D — public regulatory data, not a portfolio list published by the firm.